CTD and Kerwin Center Discussing Partnership on Cholesterol-Lowering Therapies for Alzheimer’s

CTD and Kerwin Center Discussing Partnership on Cholesterol-Lowering Therapies for Alzheimer’s
CTD Holdings and the Kerwin Research Center are discussing working together on the use of cholesterol-lowering therapies called cyclodextrins as possible treatments for Alzheimer’s disease. Cyclodextrins are non-toxic compounds made up of sugar molecules that can bind with and extract cholesterol. Preclinical-trial studies in Niemann-Pick disease and Alzheimer’s show they can protect nerve cells, suggesting they can become a potential therapy for the disorders. Scientists know high cholesterol is a risk factor for Alzheimer’s. They also know that cholesterol-lowering drugs reduce the progression of the disease. This may be because cholesterol and membrane lipid p
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *